衍生集團(06893.HK)預計中期虧損不超1800萬港元
格隆匯11月12日丨衍生集團(06893.HK)發佈公吿,公司預計截至2021年9月30日止六個月錄得綜合虧損淨額不多於約1800萬港元,對比截至2020年9月30日止六個月則錄得綜合虧損淨額約1200萬港元。
期間綜合虧損淨額預期增加,主要是由於在新冠狀病毒疫情持續影響下對香港的零售和旅遊業產生了不利影響,令本期間營業額下跌大約三成。針對上述情況,公司管理層已引入短期及長期成本削減措施,並計劃優化集團的成本架構。重點之一是把握疫情下消費者購物習慣及模式轉變,並積極促進電子商務和在線購物平台的開發和使用。公司計劃加快線下零售商店和線上業務的整合,以吸收不斷增長的線上消費者羣併為長期發展奠定堅實的基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.